Mirum Pharmaceuticals, Inc. Common Stock (NASDAQ: MIRM) last traded at $79.96, up 0.43% on the session. The quote above updates while this page is open; the figures below are drawn from Mirum Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Mirum Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker MIRM. Its market capitalisation is $5.19 billion.
Valuation measures for Mirum Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $5.19B |
|---|---|
| Enterprise value | $5.92B |
| Price / sales | 8.40 |
| Beta | 1.01 |
Trailing-twelve-month figures tagged in Mirum Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $618.07M |
| Net income (TTM) | -$860.21M |
|---|
| EPS (TTM) | -$14.54 |
|---|
| Operating margin | -134.93% |
|---|
| Cash | $330.73M |
|---|
Range and volume for MIRM over the past 52 weeks.
| 52-week high | $130.00 |
|---|---|
| 52-week low | $63.23 |
| Volume | 975.1K |
| Average volume | 719.4K |
| Previous close | $79.62 |
Invest a chosen dollar amount in Mirum Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MIRM.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.